BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25186386)

  • 1. The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions.
    Liebl J; Paganetti H; Zhu M; Winey BA
    Med Phys; 2014 Sep; 41(9):091711. PubMed ID: 25186386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
    Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
    Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-guided patient positioning in proton radiotherapy using multicriteria-optimization.
    Kurz C; Süss P; Arnsmeyer C; Haehnle J; Teichert K; Landry G; Hofmaier J; Exner F; Hille L; Kamp F; Thieke C; Ganswindt U; Valentini C; Hölscher T; Troost E; Krause M; Belka C; Küfer KH; Parodi K; Richter C
    Z Med Phys; 2019 Aug; 29(3):216-228. PubMed ID: 30409729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of uncertainties in the mean excitation energy of human tissues during proton therapy.
    Besemer A; Paganetti H; Bednarz B
    Phys Med Biol; 2013 Feb; 58(4):887-902. PubMed ID: 23337713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of in-room positron emission tomography for in vivo treatment monitoring in proton radiation therapy.
    Min CH; Zhu X; Winey BA; Grogg K; Testa M; El Fakhri G; Bortfeld TR; Paganetti H; Shih HA
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):183-9. PubMed ID: 23391817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions.
    Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F
    Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
    Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical assessment of proton treatment plans under setup and range uncertainties.
    Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer.
    Quan EM; Liu W; Wu R; Li Y; Frank SJ; Zhang X; Zhu XR; Mohan R
    Med Phys; 2013 Aug; 40(8):081709. PubMed ID: 23927306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
    Ödén J; Eriksson K; Toma-Dasu I
    Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.
    Schuemann J; Giantsoudi D; Grassberger C; Moteabbed M; Min CH; Paganetti H
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1157-1164. PubMed ID: 26025779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
    Rana S; Greco K; Samuel EJJ; Bennouna J
    J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.